Gene · 338399
TAS2R62P: taste 2 receptor member 62, pseudogene
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. TAS2R62P: taste 2 receptor member 62, pseudogene. Genes, record 338399. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/338399
On this page
Gene
Proteins0
Reviewed human proteins whose Swiss-Prot entry states the gene.
None in this release.
Patents0
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
None in this release.
Drugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,804
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | TAS2R62P papers | Newest fiscal year |
|---|---|---|---|
| R01AG034924 | mGluR5 and Phase State Dependent Synaptic Loss in Alzheimer's Disease | 8 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 6 | 2025 |
| ZIAAG000311 | ALZHEIMERS RESEARCH PROJECT: Design And Development Of Experimental Therapeutics ((Systemic & Neurodegenerative Disorders and Alzheimer's Disease) | 6 | 2025 |
| P30CA006973 | Regional Oncology Research Center | 5 | 2025 |
| P01AG026276 | Antecedent Biomarkers for Alzheimer Disease: The Adult Children Study | 4 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 4 | 2025 |
| P30DK078392 | Digestive Health Center (DHC): Bench to Bedside Research in Pediatric Digestive Disease | 4 | 2025 |
| R01AG020670 | Knockin mouse models of Alzheimer's Disease | 4 | 2025 |
| P30AG066514 | Mount Sinai Alzheimer's Disease Research Center | 3 | 2025 |
| P30CA016056 | Roswell Park Cancer Center Support Grant | 3 | 2025 |
1 to 10 of 1,804Source NIH's project files
See all 1,804 nih grantsPapers2,833
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| LncRNA Loc646329 modulates Alzheimer's disease-related phenotypes through the miR-150/WNT/β-catenin axis in cellular and APP/PS1 mouse models. | Mol Biol Rep | 2026 | 42758358 | PubTator, text mining | PubMed |
| Mitochondria-endoplasmic reticulum contact sites (MERCS/MAM): Multi-layered upstream regulators of microglial senescence in Alzheimer's disease. | Ageing Res Rev | 2026 | 42700866 | PubTator, text mining | PubMed |
| Hydrophobic Modification of Cotton Fabrics with Epoxy-Functional Polysiloxanes: Comparison of Direct Deposition and Thiol-Crosslinked Coating. | Materials (Basel) | 2026 | 42654532 | PubTator, text mining | PubMed |
| Folate Receptor Alpha (FRα/FOLR1) Immunohistochemical Expression Across Molecularly Classified Endometrial Carcinomas. | Int J Gynecol Pathol | 2026 | 42565327 | PubTator, text mining | PubMed |
| Targeting Hippocampal PTEN Suppresses Ferroptosis and Rescues Cognitive Decline in Alzheimer's Disease via Dual AKT/GSK3β/Nrf2 and AKT/STAT3 Axes. | Adv Sci (Weinh) | 2026 | 42544873 | PubTator, text mining | PubMed |
| Unlocking the Dynamics of Human SPPL2a: First Atomistic Characterization of an Alzheimer's-Linked Intramembrane Protease. | J Chem Inf Model | 2026 | 42473207 | PubTator, text mining | PubMed |
| Human IL-34 Deficiency Primes Microglia Toward Alzheimer's Disease-Associated States. | medRxiv | 2026 | 42396292 | PubTator, text mining | PubMed |
| Erratum. | Neuroendocrinology | 2026 | 42378175 | PubTator, text mining | PubMed |
| Physicochemical convergence in antibody CDR3-VH repertoires recognizing phosphorothioate-modified oligonucleotides backbone. | Front Immunol | 2026 | 42292354 | PubTator, text mining | PubMed |
| Comparative Evaluation of the Effect of Different Polishing Systems on Surface Roughness of Permanent 3D-Printed Resins and a CAD/CAM Restorative Material. | J Esthet Restor Dent | 2026 | 42233319 | PubTator, text mining | PubMed |
1 to 10 of 2,833
See all 2,833 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/338399
GET https://conductscience.org/api/genes/v1/338399/grants?page=2